cremophor el has been researched along with sdz psc 833 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heavey, C; Meenan, B; Paietta, E; Solomon, MB | 1 |
| Beliveau, R; Jetté, L; Leclerc, JM; Murphy, GF | 1 |
| Osann, K; Slater, L; Stupecky, M; Sweet, P; Wetzel, M | 1 |
| Ahn, CH; Aszalos, A; Hrycyna, CA; Hwang, M; Licht, T; Pine, PS; Yin, JJ | 1 |
| Itoh, Y; Naito, M; Nakayama, Y; Oh-hara, T; Tsuruo, T; Watanabe, T | 1 |
| Aszalos, A; Bocsi, J; Ladányi, A; Szende, B | 1 |
| Beijnen, JH; Boogerd, W; Cleypool, C; Kemper, EM; Mos, HA; van Tellingen, O; van Zandbergen, AE | 1 |
| Binkhathlan, Z; Brocks, DR; Hamdy, DA; Lavasanifar, A | 2 |
9 other study(ies) available for cremophor el and sdz psc 833
| Article | Year |
|---|---|
Differential modulation of P-glycoprotein, the multidrug resistance mediator, by Cremophor in normal versus leukemic hematopoietic cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Drug Resistance, Multiple; Glycerol; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Lymphocytes; Pharmaceutical Vehicles | 1995 |
Interaction of drugs with P-glycoprotein in brain capillaries.
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Blood-Brain Barrier; Brain; Capillaries; Cyclosporine; Cyclosporins; Drug Interactions; Glycerol; In Vitro Techniques; Iodine Radioisotopes; Male; Prazosin; Rats; Rats, Sprague-Dawley; Time Factors; Tritium | 1995 |
Comparison of cyclosporin A, verapamil, PSC-833 and cremophor EL as enhancing agents of VP-16 in murine lymphoid leukemias.
Topics: Animals; Cell Survival; Cyclosporine; Cyclosporins; Drug Synergism; Etoposide; Glycerol; Leukemia L1210; Leukemia P388; Mice; Survival Analysis; Tumor Cells, Cultured; Verapamil | 1995 |
Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Division; Cell Membrane; Cyclosporins; Glycerol; Humans; Leukemia; Transfection; Tumor Cells, Cultured; Verapamil | 1996 |
Cremophor EL reversed multidrug resistance in vitro but not in tumor-bearing mouse models.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Glycerol; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Surface-Active Agents; Tumor Cells, Cultured; Vincristine | 1996 |
Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators.
Topics: 3T3 Cells; Animals; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cyclosporins; Daunorubicin; Drug Combinations; Drug Interactions; G2 Phase; Glycerol; Mice; Verapamil | 2001 |
Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
Topics: Acridines; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Female; Glycerol; Mice; Mice, Knockout; Paclitaxel; Tetrahydroisoquinolines; Time Factors | 2003 |
Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Glycerol; Injections, Intravenous; Liver; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2010 |
Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat.
Topics: Administration, Oral; Animals; Area Under Curve; Cyclosporins; Drug Carriers; Ethanol; Excipients; Glycerol; Injections, Intravenous; Male; Micelles; Polyesters; Polymers; Protein Binding; Rats; Rats, Sprague-Dawley; Solubility; Time Factors; Tissue Distribution | 2010 |